phosphoprotein Enriched in Astrocytes 15 (PEA15) Peptide
Quick Overview for phosphoprotein Enriched in Astrocytes 15 (PEA15) Peptide (ABIN981571)
Target
Origin
Source
Application
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-PEA15 antibody (Catalog #: ARP48232_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PEA15 (phosphoprotein Enriched in Astrocytes 15 (PEA15))
-
Background
-
PEA15 is a death effector domain (DED)-containing protein predominantly expressed in the central nervous system, particularly in astrocytes.PEA15 is a death effector domain (DED)-containing protein predominantly expressed in the central nervous system, particularly in astrocytes.[supplied by OMIM]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alias Symbols: HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED
Protein Interaction Partner: AKT1,MAPK3,RPS6KA3,ABCD4,AKD1,AKT1,CAMK2G,CASP8,FADD,HTRA2,L1CAM,LUC7L2,MAPK1,MAPK3,PANK4,PLD1,PLD2,PRKCA,RPS6KA3,ABCD4,CASP8,FADD,Gm899,L1CAM,LUC7L2,MAPK1,MAPK3,PLD1,PLD2,RPS6KA3
Protein Size: 130 -
Molecular Weight
- 15 kDa
-
Gene ID
- 8682
-
NCBI Accession
- NM_003768, NP_003759
-
UniProt
- Q15121
Target
-